id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-1650-0009,FDA,FDA-2019-D-1650,"Magnetic Resonance (MR) Receive-only Coil – Performance Criteria for Safety and Performance Based Pathway; Guidance for Industry and
Food and Drug Administration Staff",Other,Guidance,2020-12-11T05:00:00Z,2020,12,2020-12-11T05:00:00Z,,2024-11-06T23:42:34Z,,1,0,09000064849987a9
FDA-2019-D-1650-0008,FDA,FDA-2019-D-1650,Performance Criteria for Safety and Performance Based Pathway; Guidances for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2020-12-11T05:00:00Z,2020,12,2020-12-11T05:00:00Z,,2020-12-11T13:54:17Z,2020-27248,0,0,0900006484998722